News

Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy

Studies led by Stony Brook University professor of chemistry Peter J. Tonge indicate that modifications that enhance the time a drug remains bound to its target, or residence time, may lead to better diagnostic and therapeutic agents.